NIH-funded research R01 grant

Bidirectional signaling by FGFs in developmental biology

Official title: Bidirectional signaling by FGF proteins

Funded at California Institute of Technology · NIH-11368564 · Data updated 2026-11-12

Researchers are studying how fibroblast growth factor proteins may signal both outside and inside cells, using a fruit-fly model to understand how this could affect development and cell behavior.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCalifornia Institute of Technology
NIH-funded
Lab location1 site (Pasadena, United States)
Project startJuly 15, 2026
Project endMarch 31, 2030
Funding year2026
Award (this year)$523,943
NIH project number1R01HL180704-01A1
Project IDNIH-11368564 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to a specific patient population in this grant; basic developmental biology work.

Less likely to help

Direct patient benefits are not the immediate focus of this basic science grant.

What this research studies

This project explores a nontraditional way FGFs may communicate, by looking at a Drosophila protein called Pyr that could send signals from inside the cell back to the outside environment. By using the early embryo and heart development as a model, the team will examine how Pyr's extracellular domain activates FGFRs and how its intracellular fragment might influence cellular pathways. The work combines biochemical methods, cell biology, and developmental biology to map these bidirectional signals, focusing on how they influence cell adhesion, migration, and gene expression. Findings could reveal new layers of FGFR signaling that might be relevant to human development and disease.

Why it matters

Potential benefit: A deeper understanding of FGF signaling could inform therapies for conditions where cell communication and migration go awry, potentially guiding future treatments.

How similar studies have gone: Bidirectional signaling concepts exist in other pathways, but bidirectional FGF/FGFR signaling is not well-documented and represents a novel area of study.

Where this research is happening

  • California Institute of Technology
    Pasadena, United States
    Active

Researchers

  • Principal investigator: Stathopoulos, Angelike — California Institute of Technology
  • Study coordinator: Stathopoulos, Angelike

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.